|
|
 |
|
Viewing report
|
|
|
|
SPECIAL REPORT: 2007 Industry Dynamics-Lessons Learned
Decision Resources, Inc., Dec 2007, Pages: 39
Executive Summary
Strategic Considerations
Stakeholder Implications
2007 in Review
Looking for the Grail
Noteworthy 2007 News and Events That Signifi cantly Impact the Pharmaceutical Industry
2007’s Problems with Drug Safety
Big Pharma’s Ongoing Productivity Problems
Ramifi cations of Biogenerics Entering the Marketplace
Ramifi cations of Patent Expiries
Ascendancy of Specialty Pharma and Biotech
Retrenching and Choosing Wisely
Blockbuster Numbers Creep Upward, but Growth Grinds Almost to a Halt
Executing Change Requires a Holistic Approach to Managing a Company
A Tale of Two Management Styles: Pfi zer Versus Schering-Plough
Management Style
Insights from the Asenapine Story
Lessons to Be Learned About Management
Choosing Wisely Has Never Been More Important
Jumping on Technology Opportunities
The Quest for Innovation: Valuable Technology Opportunities, Circa 2007
Future Lifeblood of the Pharmaceutical Industry
New Value Propositions: Value-for-Money
Increasing Power of Activist States
2007 Lessons to Be Learned
2007 State Legislative Bills
State Attorneys General Not Afraid to Litigate
2007 Spectrum Scorecard
Showcase of Decision Resources, Inc., Reports and Presentations
SPECTRUM Pharmaceutical Industry Dynamics 18-3
2007 Industry Dynamics—Lessons Learned
Tables
1. Products Gaining Blockbuster Status, 2006
2. The New Mantra: A Strategy of Focus, Late 2006-2007
3. State Activities That Will Impact the Pharmaceutical Industry Going Forward
4. Spectrum Scorecard: Pharmaceutical Industry Performance, 2007
Figures
1. The Perceived Value of Biotech Is Real: Growth in AMEX Indices, 2004-2007
2. Growth in the Number of Global Blockbusters, 1987-2006
3. Years on the Market to Reach Blockbuster Status
4. Components Central to Executing Change in a Pharmaceutical Company
5. U.S. Oncology Leaders, 2000 and 2005
6. A Blazing Mergers and Acquisition Trail for Antibody Companies, 2005-2007
7. Prescription Drug State Legislation, 2007
Customers who bought this item also bought
SPECIAL REPORT: Lessons Learned in the Pharma Industry, 2008
State of the Pharmaceutical Industry, 2008
Lessons Learned from the Current Crop of Biotech Startups
State of the Pharmaceutical Industry, 2007
Pharma R&D: Lessons Learned for Future Growth
Special Report: State of the Pharmaceutical Industry, 2009
Future Pharmaceutical Industry Trends: Long-term Opportunities Tempered by Short-term challenges
FMC: The Lessons Learned in 2007
The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
2006 Industry Dynamics: Lessons to Be Learned
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
Pharmaceutical And Biotech Growth Strategies: Future Drivers And Opportunities
|
|
|
|
